Hear the stories of four women diagnosed with breast cancer while pregnant, during breastfeeding or postpartum.
3don MSN
No doctor would take her seriously. Now N.J. mom is battling ‘horror movie’ cancer syndrome.
Felicia Willette sat down with her young son for a conversation no parent wants to have. Her doctors had discovered another ...
Distraction methods, such as use of a stress ball, are simple and effective strategies for reducing perceived stress and pain in patients during port catheter needle insertion. Distraction methods are ...
aDepartment of VIP Medical Services & Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and ...
Marcus Whitman senior Sophie Snyder is playing varsity soccer this fall despite ongoing Hodgkin's lymphoma treatment ...
An $8 billion artificial intelligence data center project in Port Washington, Wisconsin, is facing strong public opposition. Critics are concerned about the project's massive energy consumption, ...
A young cancer patient who died after refusing chemotherapy in favor of five coffee enemas a day was “adversely influenced” by her conspiracy theorist mother, a UK coroner said Thursday. Paloma ...
Halsey first revealed in June 2024 that she'd been diagnosed with a rare disorder two years prior Halsey is giving fans an update on her health over 12 months after revealing she'd been diagnosed with ...
A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients with colorectal cancer that has spread to the liver experience more severe ...
Medical malpractice: Suit alleges that medical professionals negligently placed a chemotherapy port in a patient's carotid artery instead of the jugular vein, and subsequently failed to identify the ...
Facing increased EGFR competition from a new drug combination by Johnson & Johnson, AstraZeneca has come up with its own solution to prolong the lives of patients who take the company’s decade-old ...
Adding ivonescimab, a first-in-class bispecific antibody targeting both PD-1 and VEGF, to chemotherapy significantly prolonged progression-free survival (PFS) compared to chemotherapy alone in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results